查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829719

2025年感染疾病診斷檢測全球市場報告

Infectious Disease Diagnostics Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，感染疾病診斷檢測市場呈現強勁成長勢頭，從 2024 年的 385.2 億美元擴張至 2025 年的 422.4 億美元，複合年成長率為 9.7%。這段時期的成長動力來自以下幾個面向：SARS、伊波拉出血熱和茲卡等疾病疫情的爆發；醫護人員和公眾對早期發現和預防感染疾病重要性的認知不斷提高；政府對疾病監測、控制和預防計畫的投入增加；全球旅行和貿易的增加促進了感染疾病的傳播；以及醫療保健支出的增加，尤其是在新興國家。

預計未來幾年感染疾病診斷檢測市場將強勁成長，到 2029 年將達到 607.1 億美元，複合年成長率為 9.5%。預測期內，這一成長的主要驅動力包括大流行性流感和 COVID-19 等新型病原體的不斷出現、向個性化醫療和標靶治療的轉變、對快速和現場檢測解決方案的需求增加、對流行病學監測和早期檢測系統的日益重視，以及專注於開發新型診斷技術和生物標記的研發活動的活性化。預測期內的主要趨勢包括診斷設備的小型化和便攜化、採用可同時檢測多種病原體的多重檢測、行動應用程式和遠端醫療平台等數位健康解決方案的整合、次世代定序(NGS) 技術在感染疾病診斷中的應用、用於快速靈敏地檢測傳染源的生物感測器技術的進步，以及將人工智慧和機器學習演算法中的應用、用於快速靈敏地檢測傳染源的生物感測器技術的進步，以及將人工智慧和機器學習演算法中的應用、用於快速靈敏地檢測傳染源的生物感測器技術的進步，以及將人工智慧和機器學習演算法整合到人工智慧平台中。

感染疾病診斷檢測可以識別患者體內是否有細菌、病毒、真菌和寄生蟲等病原體。這些檢測對於診斷感染疾病和確定適當的治療方法至關重要。它們在控制感染疾病傳播、選擇治療方法和監測疫情方面發揮關鍵作用。

感染疾病診斷檢測的主要類型包括感染疾病分子診斷檢測和就地檢驗(POCT)。分子診斷檢測是一種實驗室技術，透過檢測和分析遺傳物質（DNA 或 RNA）來診斷疾病、識別病原體並預測治療反應。這些檢測應用於呼吸道感染疾病、人類免疫力缺乏病毒 (HIV)、醫院相關感染疾病(HAIS)、性健康、熱帶疾病和肝病等領域。它們的最終用戶多種多樣，包括診斷實驗室、醫院和診所、學術研究機構以及其他醫療保健提供者。

2025年春季，美國關稅突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供感染疾病診斷檢測市場統計數據，例如全球市場規模、區域佔有率、感染疾病感染疾病檢測市場佔有率的競爭對手、詳細的感染疾病診斷檢測細分市場、市場趨勢以及感染疾病診斷檢測行業的商機，為您提供在傳染病檢測行業取得成功所需的診斷數據。本感染疾病診斷檢測研究報告全面概​​述了您所需的一切，並詳細分析了該行業的現狀和未來發展趨勢。

未來五年9.5%的預測成長率，較我們先前對該市場的預測略有下降0.6%。下降主要源自於美國與其他國家之間關稅的影響。美國可能會直接感受到這種影響，因為來自新加坡和義大利等關鍵地區的多重PCR試劑和自動化核酸萃取系統的供應鏈中斷，這可能導致疫情應對時間延遲和公共衛生檢測成本增加。由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易的負面影響，這種影響可能會更加廣泛。

由於呼吸道感染疾病的增加，感染疾病診斷檢測市場預計將出現成長。呼吸道感染疾病會影響呼吸系統的各個部位，是由密切接觸、不良衛生習慣、擁擠的居住環境和季節變化等導致的病毒和細菌傳播引起的。感染疾病診斷檢測對於準確識別和治療呼吸道感染疾病至關重要，可以準確檢測患者檢體中的病毒和細菌等病原體。例如，根據加拿大衛生資訊研究所的報告，預計因急性上呼吸道感染疾病住院的人數將增加 32%，從 2022 年的 2,114 例增加到 2023 年的 2,797 例。

為了保持競爭力，感染疾病診斷檢測市場的主要企業正專注於技術創新，尤其是在分子診斷平台方面。這些平台是先進的系統，旨在檢測和分析生物樣本中的核酸以用於診斷。 Becton, Dickinson and Company 最近推出了 BD COR 系統，這是一個自動化感染疾病分子診斷平台，能夠高通量處理多達 1,700 個檢體，並在 24 小時內提供結果。該平台簡化了分子實驗室工作流程，提高了 HPV 和性傳染感染等疾病的診斷效率和準確性。

2022年8月，SSI Diagnostica Group (SSID) 收購了美國感染疾病診斷產品開發商 TechLab。此次收購鞏固了 SSI Diagnostica Group 在感染疾病診斷市場的地位，並符合其擴大產品組合、增強技術和提升市場佔有率的目標。

感染疾病診斷檢測市場由提供實驗室檢測、即時檢驗、分子免疫檢測和快速診斷檢測等服務的營業單位所獲得的收益組成。市場價值包括服務提供者銷售的或包含在其服務產品中的相關產品的價值。感染疾病診斷檢測市場還包括用於檢測和識別患者傳染源的診斷試劑套件、試劑、設備和軟體的銷售。該市場的價值是“出廠價”，即產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場中的產品價值還包括產品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球感染疾病診斷測試：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球感染疾病診斷檢測市場：成長率分析
  • 全球感染疾病診斷檢測市場表現：規模與成長，2019-2024
  • 全球感染疾病診斷檢測市場預測：規模與成長，2024-2029年，2034年
  • 全球感染疾病診斷測試：總目標市場（TAM）

第6章 市場細分

  • 全球感染疾病診斷檢測市場：依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 分子診斷檢測
  • 照護現場檢驗 (POCT)感染疾病診斷檢測
  • 全球感染疾病診斷檢測市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 呼吸系統
  • 人類免疫力缺乏病毒（HIV）
  • 醫療相關感染疾病（HAI）
  • 性健康
  • 熱帶疾病
  • 肝
  • 全球感染疾病診斷檢測市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 診斷實驗室
  • 醫院和診所
  • 學術研究機構
  • 其他最終用戶
  • 全球感染疾病診斷檢測市場：依分子診斷檢測類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素鏈鎖反應（PCR）檢測
  • 核酸增幅檢查（NAAT）
  • 次世代定序（NGS）
  • 基於微陣列的偵測
  • 全球感染疾病診斷檢測市場：就地檢驗(POCT) 和感染疾病診斷檢測（按類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 橫向流動化驗
  • 快速抗原檢測
  • 免疫檢測
  • 可攜式PCR儀

第7章 區域和國家分析

  • 全球感染疾病診斷檢測市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球感染疾病診斷檢測市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 感染疾病診斷檢測市場：競爭格局
  • 感染疾病診斷檢測市場：公司簡介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Becton Dickinson And Company
  • Quest Diagnostics Incorporated
  • Grifols SA
  • Hologic Inc.
  • PerkinElmer Inc.
  • bioMerieux SA
  • Quidel Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • DiaSorin SpA（Luminex）
  • Myriad Genetics Inc.
  • Seegene Inc.
  • Ortho Clinical Diagnostics Inc.
  • OraSure Technologies Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年感染疾病診斷檢測市場：提供新機會的國家
  • 2029年感染疾病診斷檢測市場：細分領域帶來新機會
  • 2029年感染疾病診斷檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r30473u

Infectious disease diagnostics testing involves identifying the presence of pathogens, such as bacteria, viruses, fungi, or parasites, in a patient's body. These tests are critical for diagnosing infectious diseases and making appropriate treatment decisions. They play a crucial role in controlling the spread of infectious diseases, guiding treatment choices, and monitoring outbreaks.

The main types of infectious disease diagnostics testing are molecular diagnostic tests and point-of-care tests (POCT) for infectious diseases. Molecular diagnostic testing refers to laboratory techniques that detect and analyze genetic material (DNA or RNA) to diagnose diseases, identify pathogens, and predict treatment responses. These tests find applications in areas such as respiratory infections, human immunodeficiency virus (HIV), healthcare-associated infections (HAIS), sexual health, tropical diseases, and liver diseases. They are utilized by various end-users including diagnostic laboratories, hospitals and clinics, academic research institutes, and other healthcare providers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The infectious disease diagnostics testing market research report is one of a series of new reports from The Business Research Company that provides infectious disease diagnostics testing market statistics, including infectious disease diagnostics testing industry global market size, regional shares, competitors with an infectious disease diagnostics testing market share, detailed infectious disease diagnostics testing market segments, market trends, and opportunities, and any further data you may need to thrive in the infectious disease diagnostics testing industry. This infectious disease diagnostics testing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The infectious disease diagnostics testing market size has grown strongly in recent years. It will grow from $38.52 billion in 2024 to $42.24 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to rising disease outbreaks such as SARS, Ebola, and Zika, growing awareness among healthcare professionals and the general public about the importance of early detection and prevention of infectious diseases, rise in government-funded programs for disease surveillance, control, and prevention, increasing global travel and trade have facilitated the spread of infectious diseases, and increased healthcare spending, particularly in emerging economies.

The infectious disease diagnostics testing market size is expected to see strong growth in the next few years. It will grow to $60.71 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to the continuous emergence of novel pathogens, such as new strains of influenza or COVID-19es, the shift towards personalized medicine and targeted therapies, increasing demand for rapid and on-site testing solutions, Growing emphasis on epidemiological surveillance and early detection systems, and increased research and developments activities focused on developing novel diagnostic technologies and biomarkers. Major trends in the forecast period include miniaturization and portability of diagnostic devices, adoption of multiplex assays capable of detecting multiple pathogens simultaneously, integration of digital health solutions, such as mobile apps and telemedicine platforms, adoption of next-generation sequencing (NGS) technologies in infectious disease diagnostics, advancements in biosensor technologies for rapid and sensitive detection of infectious agents, and integration of AI and machine learning algorithms into diagnostic platforms.

The forecast of 9.5% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for multiplex PCR reagents and automated nucleic acid extraction systems, sourced from key regions such as Singapore and Italy, which could lead to slower outbreak response times and increased costs for public health testing.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The infectious disease diagnostic testing market is anticipated to experience growth due to an increase in respiratory infections. Respiratory infections affect various parts of the respiratory system and are caused by viral and bacterial transmission through close contact, poor hygiene, crowded living conditions, and seasonal variations. Diagnostic testing for infectious diseases is crucial for accurate identification and treatment of respiratory infections, enabling the precise detection of pathogens such as viruses and bacteria in patient samples. For example, hospitalizations for acute upper respiratory infections saw a 32% increase from 2,114 cases in 2022 to 2,797 cases in 2023, as reported by the Canadian Institute for Health Information.

Leading companies in the infectious disease diagnostic testing market are focusing on innovation, particularly in molecular diagnostics platforms, to remain competitive. These platforms are sophisticated systems designed to detect and analyze nucleic acids from biological samples for diagnostic purposes. Becton Dickinson and Company recently launched the BD COR System, an automated infectious disease molecular diagnostics platform capable of high-throughput processing of up to 1,700 specimens with results delivered within 24 hours. This platform streamlines the molecular laboratory workflow, enhancing efficiency and diagnostic accuracy for diseases such as HPV and STIs.

In August 2022, SSI Diagnostica Group (SSID) acquired TechLab Inc., a US-based developer of infectious disease diagnostic products. This acquisition strengthens SSI Diagnostica Group's position in the infectious disease diagnostics market, aligning with their objectives of portfolio expansion, technological enhancement, and market share growth.

Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Myriad Genetics Inc., Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC, Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.

North America was the largest region in the infectious disease diagnostics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the infectious disease diagnostics testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The infectious disease diagnostics testing market consists of revenues earned by entities by providing services such as laboratory testing, point-of-care testing, molecular diagnostics, immunoassays, and rapid diagnostic tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The infectious disease diagnostics testing market also includes sales of diagnostic kits, reagents, instruments, and software used for detecting and identifying infectious agents in patients. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infectious Disease Diagnostics Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on infectious disease diagnostics testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for infectious disease diagnostics testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The infectious disease diagnostics testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Molecular Diagnostic Test; Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
  • 2) By Application: Respiratory; Human Immunodeficiency Virus (HIV); Healthcare-Associated Infections (HAIs); Sexual Health; Tropical Diseases; Liver
  • 3) By End-User: Diagnostic Laboratories; Hospitals And Clinics; Academic Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests; Nucleic Acid Amplification Tests (NAATs); Next-Generation Sequencing (NGS); Microarray-Based Tests
  • 2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays; Rapid Antigen Tests; Immunoassays; Portable PCR
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Becton Dickinson And Company; Quest Diagnostics Incorporated; Grifols S.A.; Hologic Inc.; PerkinElmer Inc.; bioMerieux SA; Quidel Corporation; Sysmex Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; DiaSorin SpA (Luminex); Myriad Genetics Inc.; Seegene Inc.; Ortho Clinical Diagnostics Inc.; OraSure Technologies Inc.; Meridian Bioscience Inc.; Trinity Biotech PLC; Biodesix Inc.; Helix OpCo LLC; Inovio Pharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Infectious Disease Diagnostics Testing Market Characteristics

3. Infectious Disease Diagnostics Testing Market Trends And Strategies

4. Infectious Disease Diagnostics Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Infectious Disease Diagnostics Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Infectious Disease Diagnostics Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Infectious Disease Diagnostics Testing Market Growth Rate Analysis
  • 5.4. Global Infectious Disease Diagnostics Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Infectious Disease Diagnostics Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Infectious Disease Diagnostics Testing Total Addressable Market (TAM)

6. Infectious Disease Diagnostics Testing Market Segmentation

  • 6.1. Global Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Diagnostic Test
  • Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
  • 6.2. Global Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Respiratory
  • Human Immunodeficiency Virus (HIV)
  • Healthcare Associated Infections (HAIs)
  • Sexual Health
  • Tropical Diseases
  • Liver
  • 6.3. Global Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Laboratories
  • Hospitals And Clinics
  • Academic Research Institutes
  • Other End-Users
  • 6.4. Global Infectious Disease Diagnostics Testing Market, Sub-Segmentation Of Molecular Diagnostic Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR) Tests
  • Nucleic Acid Amplification Tests (NAATs)
  • Next-Generation Sequencing (NGS)
  • Microarray-Based Tests
  • 6.5. Global Infectious Disease Diagnostics Testing Market, Sub-Segmentation Of Point Of Care Tests (POCT) Infectious Disease Diagnostics Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lateral Flow Assays
  • Rapid Antigen Tests
  • Immunoassays
  • Portable PCR

7. Infectious Disease Diagnostics Testing Market Regional And Country Analysis

  • 7.1. Global Infectious Disease Diagnostics Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Infectious Disease Diagnostics Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Infectious Disease Diagnostics Testing Market

  • 8.1. Asia-Pacific Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Infectious Disease Diagnostics Testing Market

  • 9.1. China Infectious Disease Diagnostics Testing Market Overview
  • 9.2. China Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Infectious Disease Diagnostics Testing Market

  • 10.1. India Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Infectious Disease Diagnostics Testing Market

  • 11.1. Japan Infectious Disease Diagnostics Testing Market Overview
  • 11.2. Japan Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Infectious Disease Diagnostics Testing Market

  • 12.1. Australia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Infectious Disease Diagnostics Testing Market

  • 13.1. Indonesia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Infectious Disease Diagnostics Testing Market

  • 14.1. South Korea Infectious Disease Diagnostics Testing Market Overview
  • 14.2. South Korea Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Infectious Disease Diagnostics Testing Market

  • 15.1. Western Europe Infectious Disease Diagnostics Testing Market Overview
  • 15.2. Western Europe Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Infectious Disease Diagnostics Testing Market

  • 16.1. UK Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Infectious Disease Diagnostics Testing Market

  • 17.1. Germany Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Infectious Disease Diagnostics Testing Market

  • 18.1. France Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Infectious Disease Diagnostics Testing Market

  • 19.1. Italy Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Infectious Disease Diagnostics Testing Market

  • 20.1. Spain Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Infectious Disease Diagnostics Testing Market

  • 21.1. Eastern Europe Infectious Disease Diagnostics Testing Market Overview
  • 21.2. Eastern Europe Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Infectious Disease Diagnostics Testing Market

  • 22.1. Russia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Infectious Disease Diagnostics Testing Market

  • 23.1. North America Infectious Disease Diagnostics Testing Market Overview
  • 23.2. North America Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Infectious Disease Diagnostics Testing Market

  • 24.1. USA Infectious Disease Diagnostics Testing Market Overview
  • 24.2. USA Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Infectious Disease Diagnostics Testing Market

  • 25.1. Canada Infectious Disease Diagnostics Testing Market Overview
  • 25.2. Canada Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Infectious Disease Diagnostics Testing Market

  • 26.1. South America Infectious Disease Diagnostics Testing Market Overview
  • 26.2. South America Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Infectious Disease Diagnostics Testing Market

  • 27.1. Brazil Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Infectious Disease Diagnostics Testing Market

  • 28.1. Middle East Infectious Disease Diagnostics Testing Market Overview
  • 28.2. Middle East Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Infectious Disease Diagnostics Testing Market

  • 29.1. Africa Infectious Disease Diagnostics Testing Market Overview
  • 29.2. Africa Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Infectious Disease Diagnostics Testing Market Competitive Landscape And Company Profiles

  • 30.1. Infectious Disease Diagnostics Testing Market Competitive Landscape
  • 30.2. Infectious Disease Diagnostics Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Infectious Disease Diagnostics Testing Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson And Company
  • 31.2. Quest Diagnostics Incorporated
  • 31.3. Grifols S.A.
  • 31.4. Hologic Inc.
  • 31.5. PerkinElmer Inc.
  • 31.6. bioMerieux SA
  • 31.7. Quidel Corporation
  • 31.8. Sysmex Corporation
  • 31.9. Bio-Rad Laboratories Inc.
  • 31.10. QIAGEN N.V.
  • 31.11. DiaSorin SpA (Luminex)
  • 31.12. Myriad Genetics Inc.
  • 31.13. Seegene Inc.
  • 31.14. Ortho Clinical Diagnostics Inc.
  • 31.15. OraSure Technologies Inc.

32. Global Infectious Disease Diagnostics Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Infectious Disease Diagnostics Testing Market

34. Recent Developments In The Infectious Disease Diagnostics Testing Market

35. Infectious Disease Diagnostics Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Infectious Disease Diagnostics Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Infectious Disease Diagnostics Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Infectious Disease Diagnostics Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer